# Wound Healing and Surgical Site Infection in Vascular Surgery ## Introduction Wound complications represent some of the most frequent morbidities following vascular surgery, with incidence rates ranging from 5% to 40% depending on the specific procedure and patient-related risk factors. The unique challenges in vascular surgery arise from the presence of prosthetic graft materials, ischemic tissue beds, and the complexity of the patient population, all of which contribute to a heightened susceptibility to wound healing failure and surgical site infection (SSI). A thorough understanding of the biological processes underlying wound healing, along with effective prevention and management strategies, is therefore essential for optimizing patient outcomes. ## Wound Healing Biology ### Phases of Wound Healing Wound healing progresses through several well-defined phases. The initial phase, hemostasis, occurs within minutes and involves platelet aggregation and the formation of a fibrin clot to stop bleeding. This is followed by the inflammation phase, lasting from day one to day five, during which neutrophils and macrophages infiltrate the wound site, releasing cytokines and clearing bacteria. The proliferation phase spans approximately days five to twenty-one and is characterized by fibroblast migration, collagen synthesis, angiogenesis, granulation tissue formation, and epithelialization. Finally, the remodeling phase extends over weeks to months, during which collagen fibers undergo cross-linking and reorganization, the wound contracts, and the tensile strength of the tissue gradually reaches about 80% of that of normal tissue. ### Factors Impairing Wound Healing Several factors can impair this complex healing process. Locally, ischemia, infection, the presence of foreign bodies such as graft material, radiation exposure, and excessive tension on wound edges can all hinder healing. Systemic factors include diabetes mellitus, malnutrition—particularly when serum albumin falls below 3.0 g/dL—smoking, immunosuppression, chronic kidney disease, and obesity. Certain medications, such as corticosteroids, chemotherapeutic agents, and antiproliferative immunosuppressants, also negatively affect wound repair. Technical aspects during surgery, including excessive use of electrocautery, the creation of dead space, hematoma formation, and overly tight skin closure, further contribute to wound healing complications. ## Surgical Site Infection in Vascular Surgery ### Classification Surgical site infections are classified based on the depth and timing of involvement. Superficial incisional SSIs affect only the skin and subcutaneous tissue within 30 days postoperatively. Deep incisional SSIs involve the fascial and muscle layers and occur within 30 days, or up to 90 days if an implant is present. Organ/space SSIs affect any anatomical space that was opened or manipulated during surgery, such as infections involving vascular grafts. ### Risk Factors Specific to Vascular Surgery Certain risk factors are particularly relevant in vascular surgery. Groin incisions carry the highest SSI rates, ranging from 10% to 30%, due to their proximity to the perineum, disruption of lymphatic channels, and colonization by skin flora. The implantation of prosthetic grafts, redo surgeries, revision procedures, emergency operations, prolonged operative times exceeding four hours, and the presence of concurrent tissue loss or gangrene all increase infection risk. Additionally, obesity, defined as a body mass index greater than 30, and redundant skin folds over incisions further predispose patients to SSIs. ### Microbiology The most common pathogen isolated in vascular SSIs is Staphylococcus aureus, including methicillin-resistant strains (MRSA). Coagulase-negative staphylococci are frequently implicated in prosthetic graft infections. Gram-negative organisms such as Escherichia coli and Pseudomonas species are often found in groin wound infections. Polymicrobial infections are common in ischemic tissue and diabetic wounds. ![Groin wound infection following femoral artery bypass with exposed prosthetic graft](images/groin-ssi-exposed-graft.jpg) ## Prevention Strategies ### Preoperative Preoperative measures to reduce SSI risk include bathing with chlorhexidine gluconate the night before and the morning of surgery. Nasal decolonization with mupirocin is recommended for MRSA carriers, or universal decolonization protocols may be employed. Optimizing glycemic control to maintain blood glucose levels below 180 mg/dL during the perioperative period is crucial. Smoking cessation should be initiated at least four weeks prior to elective surgery. Nutritional status should be optimized, aiming for serum albumin levels above 3.0 g/dL and prealbumin levels greater than 15 mg/dL. ### Intraoperative Intraoperative prevention involves administering antibiotic prophylaxis, typically cefazolin 2 grams intravenously within 60 minutes before incision, with redosing every three to four hours for prolonged procedures. Vancomycin is added for MRSA carriers or in institutions with a high prevalence of MRSA. Meticulous hemostasis and elimination of dead space are essential. Coverage of femoral grafts in the groin with a sartorius muscle flap reduces graft exposure. When dead space cannot be avoided, closed-suction drains help prevent seroma and hematoma formation. Minimizing tissue handling and preserving lymphatic channels in the groin are also important to reduce infection risk. ### Postoperative Postoperatively, maintaining normoglycemia with blood glucose levels below 180 mg/dL for 48 to 72 hours supports wound healing. Incision care involves sterile occlusive dressings applied for 24 to 48 hours. Early identification and management of wound complications such as seroma, hematoma, and lymphocele are critical. The use of negative pressure wound therapy (NPWT) over closed incisions, known as closed-incision NPWT (ciNPWT), has been shown to reduce SSI rates in high-risk groin wounds. ![Closed-incision negative pressure wound therapy applied to a groin incision following femoral bypass](images/cinpwt-groin-incision.jpg) ## Management of Wound Complications ### Wound Dehiscence Management of wound dehiscence begins with identifying and addressing contributing factors such as infection, hematoma, malnutrition, and excessive tension on wound edges. Superficial dehiscence can often be managed with local wound care, packing, secondary intention healing, or NPWT. However, deep dehiscence with exposure of a vascular graft requires urgent operative intervention, typically involving muscle flap coverage to protect the graft. ### Surgical Site Infection Superficial SSIs are managed by opening the wound, obtaining cultures, administering targeted antibiotics, and providing local wound care. Deep SSIs involving grafts necessitate operative debridement, with graft-specific management strategies that may include partial or complete excision of the infected graft, muscle flap coverage, and prolonged antibiotic therapy. Strategies to preserve grafts include the use of antibiotic-impregnated beads and continuous irrigation systems. ### Lymphatic Complications Lymphocele and lymphorrhea are common complications following groin dissection. These are generally managed with compression, aspiration, or sclerotherapy. Prevention focuses on meticulous ligation of lymphatic channels during groin dissection and avoiding vertical groin incisions when possible. ![Algorithm for management of groin wound complications after vascular surgery](images/groin-wound-management-algorithm.jpg) ## Key Clinical Pearls Groin wounds represent the Achilles heel of vascular surgery, and prevention strategies should be consistently applied for every groin incision. The sartorius muscle flap is a straightforward technique that effectively reduces the risk of prosthetic graft exposure in the groin. Closed-incision negative pressure wound therapy has emerged as a valuable adjunct in managing high-risk wounds. Preoperative optimization of nutrition and glycemic control are modifiable risk factors that significantly influence wound healing outcomes. Importantly, any wound infection overlying a prosthetic graft must be treated as a graft infection until proven otherwise. ## References 1. Defined, Defined, et al. "Surgical site infections after vascular surgery: risk factors and preventive strategies." *J Vasc Surg*. 2017;65(2):539-548. 2. Defined, Defined, et al. "Closed-incision negative pressure therapy reduces surgical site infections in vascular surgery." *J Vasc Surg*. 2016;64(6):1776-1782. 3. Berrios-Torres SI, Umscheid CA, et al. "Centers for Disease Control and Prevention guideline for the prevention of surgical site infection." *JAMA Surg*. 2017;152(8):784-791. 4. Defined, Defined, et al. "Sartorius muscle flap harvest for coverage of vascular prostheses in the groin." *J Vasc Surg*. 2013;57(5):1370-1375.